SNPX (Neurotrope) Net earnings per share growth forecast for next year

Corporate company logo of Synaptogenix Inc. (SNPX)

Synaptogenix, Inc. is advancing neuropharmaceuticals through partnerships with dementia research institutes, accelerating therapies for Alzheimer's disease. The company's innovations focus on regenerating neural connections by activating brain enzymes. Next year's EPS forecast trends reflect analyst expectations, with the value fixed at 0.00. Operational activities are strictly regulated by FDA standards regarding the disposal of biomaterials.

SNPX: Synaptogenix Inc. Net earnings per one share growth forecast for next year 07/04/2022 - 05/02/2026

Analytical breakdowns for synaptogen.com (SNPX)

- stock quotes and analyst forecast:
Stock Quotes Neurotrope|SNPX - Analyst Forecast Prices
- business market valuation indicators:
Market Value Synaptogenix|SNPX - Total Enterprise Value
- company book value details:
Book Value per Share Synaptogenix|SNPX - Book Value of Business|Market Capitalization to Book Value Ratio synaptogen.com|SNPX - Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Synaptogenix, Inc.|SNPX - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Synaptogenix|SNPX - Company Total Debt Obligations|Debt to Book Value Synaptogenix|SNPX - Company Long-Term Indebtedness|Company Current Liabilities Synaptogenix|Quick Ratio synaptogen.com
- earnings and valuation multiples information:
SNPX - Net Financial Result|Expected Profit Synaptogenix, Inc.|SNPX - Price to Earnings Multiple|Forward P/E Multiple Synaptogenix, Inc.|SNPX - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Synaptogenix|SNPX - Operating income before deduction of amortization|Earnings per share for the last twelve months Synaptogenix|SNPX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months synaptogen.com|SNPX - Earnings per share growth this year|Net earnings per share growth forecast for next year Synaptogenix, Inc.
- sales and revenue data:
SNPX - Company Annual Revenue|Company Future Sales Volume Neurotrope|SNPX - Market Cap to Revenue Ratio|Price-to-Projected Revenue Ratio Synaptogenix
Initial company analysis:Neurotrope
Core merchandise of synaptogen.com

This indicator reflects the consensus forecast for earnings per share changes, measuring expected business efficiency through the lens of future cash flows and market expectations. By analyzing the projected EPS dynamics for the next period, investors assess the probability of commercializing the developments of Synaptogenix, Inc. (SNPX), where growth in this metric depends directly on FDA regulatory approval and the securing of external funding to complete clinical trials.

Competing companies

Expected earnings per share growth for next year BIIB|NBIX (Neurocrine Corp) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year Regencell Bioscience (RGC)|AXSM - Expected net earnings per share growth next year|Earnings growth forecast for next year ACAD (ACADIA Pharmaceuticals Inc.)|Net earnings per one share growth forecast for next year Xenon Pharmaceuticals Inc.|Viking Pharma - Earnings growth forecast for next year|Expected net earnings per share growth next year Supernus Corp|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year DNLI|HRMY (Harmony Biosciences Holdings, Inc.) - Earnings growth forecast for next year|Biohaven Ltd (BHVN) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year AMLX (Amylyx)|Trevi Corp - Projected earnings per share growth rate for next year|Praxis Precision Medicines - Expected earnings per share growth for next year|Expected earnings per share trend next year AVXL|CeriBell - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Prothena Corporation plc PRTA|alector.com (ALEC) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year ANNX|OMER (Omeros Corp) - Earnings growth forecast for next year|Expected earnings per share growth for next year neurogene.com (NGNE)|Expected earnings per share growth for next year ACIU (AC Immune SA)|Consensus forecast of earnings per share growth for next year Voyager Therapeutics Inc|Net earnings per share growth forecast for next year Neumora Therapeutics Inc NMRA|Consensus forecast of earnings per share growth for next year Scilex Holding Company, Inc. (SCLX)|TVGN - Net earnings per share growth forecast for next year|ACOG (Alpha Cognition) - Projected earnings per share growth rate for next year|Cognition Therapeutics (CGTX) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year IKT (Inhibikase Therapeutics Inc)|Expected earnings per share growth for next year SAVA|Projected earnings per share growth rate for next year ASRT (Assertio Therapeutics)|Net earnings per share growth forecast for next year Coya Therapeutics, Inc. (COYA)|vistagen.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year OVID (Ovid Therapeutics)|Acumen Pharmaceuticals Inc. (ABOS) - Expected net earnings per share growth next year|CRVO: Expected earnings per share growth for next year|ATHE - Earnings growth forecast for next year|clene.com (CLNN) - Net earnings per share growth forecast for next year|PepGen - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Jupiter Neurosciences Inc|Expected net earnings per share growth next year Relmada Therapeutics Inc RLMD|Net earnings per share growth forecast for next year Annovis Bio Corp (ANVS)|Consensus forecast of earnings per share growth for next year gracetx.com|Firefly Neuroscience, Inc - Expected earnings per share growth for next year|ANEW Medical (KLTO) - Expected net earnings per share growth next year|NRSN - Net earnings per share growth forecast for next year|RVPH (Reviva Pharmaceuticals Holdings Inc.) - Projected earnings per share growth rate for next year|MTVA: Earnings growth forecast for next year|NeurAxis Inc (NRXS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Helius Medical Technologies, Inc.|Passage Bio Corp - Net earnings per share change forecast for next year|Expected earnings per share growth for next year NEUP (Neuphoria Therapeutics Inc.)|Projected earnings per share increase next year NERV|Net earnings per share growth forecast for next year Athira ATHA|Addex (ADXN) - Expected net earnings per share growth next year|Alzamend - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Cyclerion Therapeutics (CYCN)|PTIX: Earnings growth forecast for next year|Expected net earnings per share growth next year Pasithea Therapeutics Corp. (KTTA)|Net earnings per share growth forecast for next year Cortigent Inc|Projected earnings per share growth rate for next year ATXI (Avenue Therapeutics Inc)|Earnings growth forecast for next year BCLI|Consensus forecast of earnings per share growth for next year caratherapeutics.com|Chromocell Therapeutics Corp. - Expected earnings per share growth for next year|ELYM: Projected earnings per share growth rate for next year|ITCI: Expected earnings per share growth for next year|Expected earnings per share trend next year LBPH (Longboard)|MRNS: Earnings growth forecast for next year|NKGN - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year NeuroBo Pharmaceuticals, Inc.|Projected earnings per share growth rate for next year SAGE (Sage Therapeutics Inc.)|Earnings growth forecast for next year TRVN|Expected earnings per share growth for next year vigilneuro.com VIGL|Anew Medical - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year cerevel.com (CERE)